214 related articles for article (PubMed ID: 18727021)
41. Enhancing percutaneous delivery of methotrexate using different types of surfactants.
Javadzadeh Y; Hamishehkar H
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):422-6. PubMed ID: 20951009
[TBL] [Abstract][Full Text] [Related]
42. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
Vemulapalli V; Yang Y; Friden PM; Banga AK
J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
[TBL] [Abstract][Full Text] [Related]
43. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
Fang JY; Hwang TL; Huang YB; Tsai YH
Int J Pharm; 2002 Mar; 235(1-2):95-105. PubMed ID: 11879744
[TBL] [Abstract][Full Text] [Related]
44. Topical delivery of active principles: the field of dermatological research.
Nino M; Calabrò G; Santoianni P
Dermatol Online J; 2010 Jan; 16(1):4. PubMed ID: 20137746
[TBL] [Abstract][Full Text] [Related]
45. Low-fluence 1,064-nm laser hair reduction for pseudofolliculitis barbae in skin types IV, V, and VI.
Schulze R; Meehan KJ; Lopez A; Sweeney K; Winstanley D; Apruzzese W; Victor Ross E
Dermatol Surg; 2009 Jan; 35(1):98-107. PubMed ID: 19076188
[TBL] [Abstract][Full Text] [Related]
46. Treatment of melasma using variable square pulse Er:YAG laser resurfacing.
Wanitphakdeedecha R; Manuskiatti W; Siriphukpong S; Chen TM
Dermatol Surg; 2009 Mar; 35(3):475-81; discussion 481-2. PubMed ID: 19250309
[TBL] [Abstract][Full Text] [Related]
47. Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery.
Wong TW; Chen CH; Huang CC; Lin CD; Hui SW
J Control Release; 2006 Feb; 110(3):557-65. PubMed ID: 16356576
[TBL] [Abstract][Full Text] [Related]
48. Skin laser treatments enhancing transdermal delivery of ALA.
Gómez C; Costela Á; García-Moreno I; Llanes F; Teijón JM; Blanco MD
J Pharm Sci; 2011 Jan; 100(1):223-31. PubMed ID: 20589948
[TBL] [Abstract][Full Text] [Related]
49. Enhancement of transepidermal skin clearing agent delivery using a 980 nm diode laser.
Stumpp OF; Welch AJ; Milner TE; Neev J
Lasers Surg Med; 2005 Oct; 37(4):278-85. PubMed ID: 16196039
[TBL] [Abstract][Full Text] [Related]
50. Skin electroporation for transdermal and topical delivery.
Denet AR; Vanbever R; Préat V
Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
[TBL] [Abstract][Full Text] [Related]
51. Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivatives.
Hsiao CY; Huang CH; Hu S; Ko YS; Sung HC; Huang SY
Lasers Med Sci; 2011 May; 26(3):369-76. PubMed ID: 21120566
[TBL] [Abstract][Full Text] [Related]
52. Shear bond strength of a sealant to contaminated-enamel surface: influence of erbium : yttrium-aluminum-garnet laser pretreatment.
Lepri TP; Souza-Gabriel AE; Atoui JA; Palma-Dibb RG; Pécora JD; Milori Corona SA
J Esthet Restor Dent; 2008; 20(6):386-92; discussion 393-4. PubMed ID: 19120785
[TBL] [Abstract][Full Text] [Related]
53. Fractional carbon dioxide laser treatment to enhance skin permeation of ascorbic acid 2-glucoside with minimal skin disruption.
Hsiao CY; Huang CH; Hu S; Ko YS; Sung HC; Chen CC; Huang SY
Dermatol Surg; 2012 Aug; 38(8):1284-93. PubMed ID: 22672633
[TBL] [Abstract][Full Text] [Related]
54. Full-face treatments with the 2790-nm erbium:YSGG laser system.
Ross EV; Swann M; Soon S; Izadpanah A; Barnette D; Davenport S
J Drugs Dermatol; 2009 Mar; 8(3):248-52. PubMed ID: 19271372
[TBL] [Abstract][Full Text] [Related]
55. Histologic effects of laser-assisted topical anesthesia in a porcine model.
Singer DD; Singer AJ; McClain SA; Tortora G
Acad Emerg Med; 2005 Dec; 12(12):1148-52. PubMed ID: 16293894
[TBL] [Abstract][Full Text] [Related]
56. Effect of Er:YAG and CO2 lasers with and without sodium fluoride gel on dentinal tubules: a scanning electron microscope examination.
Cakar G; Kuru B; Ipci SD; Aksoy ZM; Okar I; Yilmaz S
Photomed Laser Surg; 2008 Dec; 26(6):565-71. PubMed ID: 19099386
[TBL] [Abstract][Full Text] [Related]
57. Skin Pretreatment With Conventional Non-Fractional Ablative Lasers Promote the Transdermal Delivery of Tranexamic Acid.
Hsiao CY; Sung HC; Hu S; Huang CH
Dermatol Surg; 2016 Jul; 42(7):867-74. PubMed ID: 27286416
[TBL] [Abstract][Full Text] [Related]
58. Laser assisted drug delivery: a review of an evolving technology.
Sklar LR; Burnett CT; Waibel JS; Moy RL; Ozog DM
Lasers Surg Med; 2014 Apr; 46(4):249-62. PubMed ID: 24664987
[TBL] [Abstract][Full Text] [Related]
59. Lasers as an approach for promoting drug delivery via skin.
Lin CH; Aljuffali IA; Fang JY
Expert Opin Drug Deliv; 2014 Apr; 11(4):599-614. PubMed ID: 24490743
[TBL] [Abstract][Full Text] [Related]
60. Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot study.
van Lingen RG; de Jong EM; van Erp PE; van Meeteren WS; van De Kerkhof PC; Seyger MM
Eur J Dermatol; 2008; 18(6):671-6. PubMed ID: 18955206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
